Magdalena Śmiech

6PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHorticultural crop improvement (incl. selection and breeding)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 05, 2024
Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.

Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska

|Jan 27, 2024
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.

Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska

|Jun 02, 2021
NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.

Effi Haque, Magdalena Śmiech, Kamila Łuczyńska

|Apr 30, 2021
Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets.

Vancha Harish, Effi Haque, Magdalena Śmiech

|Nov 17, 2020
Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks.

Magdalena Śmiech, Paweł Leszczyński, Hidetoshi Kono

Pageof 1